Manulife (Manufacturers Life Insurance)
BMRN icon

Manulife (Manufacturers Life Insurance)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.56M Sell
133,750
-2,310
-2% -$135K 0.01% 997
2025
Q4 		$8.09M Sell
136,060
-3,420
-2% -$186K 0.01% 981
2025
Q3 		$7.55M Buy
139,480
+821
+0.6% +$47K 0.01% 1006
2025
Q2 		$7.62M Sell
138,659
-608
-0.4% -$35.8K 0.01% 964
2025
Q1 		$9.84M Sell
139,267
-15,029
-10% -$1.01M 0.01% 838
2024
Q4 		$10.1M Sell
154,296
-5,621
-4% -$377K 0.01% 881
2024
Q3 		$11.2M Sell
159,917
-20,700
-11% -$1.73M 0.01% 843
2024
Q2 		$14.9M Buy
180,617
+115,578
+178% +$9.62M 0.01% 695
2024
Q1 		$5.68M Sell
65,039
-9,365
-13% -$838K 0.01% 1134
2023
Q4 		$7.17M Buy
74,404
+11,709
+19% +$1.04M ﹤0.01% 999
2023
Q3 		$5.55M Buy
62,695
+7,125
+13% +$634K ﹤0.01% 1069
2023
Q2 		$4.82M Sell
55,570
-2,890
-5% -$272K ﹤0.01% 1091
2023
Q1 		$5.68M Buy
58,460
+19,510
+50% +$2.02M ﹤0.01% 1015
2022
Q4 		$3.99M Buy
38,950
+13,689
+54% +$1.29M ﹤0.01% 1162
2022
Q3 		$2.15M Buy
25,261
+4,149
+20% +$369K ﹤0.01% 1366
2022
Q2 		$1.77M Buy
21,112
+15
+0.1% +$1.19K ﹤0.01% 1444
2022
Q1 		$1.64M Buy
21,097
+17,791
+538% +$1.49M ﹤0.01% 1559
2021
Q4 		$292 Sell
3,306
-452
-12% -$37.3K ﹤0.01% 2615
2021
Q3 		$290K Hold
3,758
– – ﹤0.01% 2695
2021
Q2 		$314K Hold
3,758
– – ﹤0.01% 2783
2021
Q1 		$284K Hold
3,758
– – ﹤0.01% 2652
2020
Q4 		$330K Hold
3,758
– – ﹤0.01% 2455
2020
Q3 		$286K Hold
3,758
– – ﹤0.01% 2326
2020
Q2 		$459K Sell
3,758
-498
-12% -$49.5K ﹤0.01% 2011
2020
Q1 		$360K Sell
4,256
-247
-5% -$21.3K ﹤0.01% 1989
2019
Q4 		$381K Sell
4,503
-155
-3% -$11.7K ﹤0.01% 2202
2019
Q3 		$318K Sell
4,658
-205
-4% -$15.8K ﹤0.01% 2287
2019
Q2 		$417K Sell
4,863
-234
-5% -$20K ﹤0.01% 2155
2019
Q1 		$453K Sell
5,097
-45
-0.9% -$4.17K ﹤0.01% 2142
2018
Q4 		$438K Buy
5,142
+5
+0.1% +$476 ﹤0.01% 2036
2018
Q3 		$498K Sell
5,137
-1,330
-21% -$133K ﹤0.01% 2299
2018
Q2 		$609K Sell
6,467
-76
-1% -$6.66K ﹤0.01% 2221
2018
Q1 		$530K Sell
6,543
-195
-3% -$16.7K ﹤0.01% 2286
2017
Q4 		$600K Sell
6,738
-495
-7% -$43K ﹤0.01% 2199
2017
Q3 		$673K Buy
7,233
+435
+6% +$38.4K ﹤0.01% 2064
2017
Q2 		$617K Buy
6,798
+812
+14% +$73.9K ﹤0.01% 2127
2017
Q1 		$525K Buy
5,986
+312
+5% +$27.8K ﹤0.01% 2148
2016
Q4 		$470K Sell
5,674
-126
-2% -$10.8K ﹤0.01% 2142
2016
Q3 		$536K Buy
5,800
+119
+2% +$11.2K ﹤0.01% 2037
2016
Q2 		$441K Buy
5,681
+70
+1% +$5.95K ﹤0.01% 2120
2016
Q1 		$438K Buy
5,611
+151
+3% +$12.3K ﹤0.01% 2051
2015
Q4 		$572 Hold
5,460
– – ﹤0.01% 1941
2015
Q3 		$575 Buy
5,460
+36
+0.7% +$4.81K ﹤0.01% 1910
2015
Q2 		$742 Buy
5,424
+276
+5% +$34.2K ﹤0.01% 1860
2015
Q1 		$641 Buy
5,148
+29
+0.6% +$3.07K ﹤0.01% 1944
2014
Q4 		$463 Buy
5,119
+8
+0.2% +$665 ﹤0.01% 2035
2014
Q3 		$368 Sell
5,111
-1,184
-19% -$77.8K ﹤0.01% 2197
2014
Q2 		$392K Sell
6,295
-134
-2% -$8.1K ﹤0.01% 2207
2014
Q1 		$439 Hold
6,429
– – ﹤0.01% 2163
2013
Q4 		$452 Sell
6,429
-384
-6% -$26.1K ﹤0.01% 2126
2013
Q3 		$492 Buy
6,813
+1,195
+21% +$79.4K ﹤0.01% 2004
2013
Q2 		$314K Buy
+5,618
New +$350K ﹤0.01% 2208

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BMRN Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its BioMarin Pharmaceuticals (BMRN) stake by 1.7% in Q1 2026, selling an estimated $135K and leaving 133,750 shares worth $7.56M. The position accounts for 0.01% of the portfolio, ranked #997.

Manulife (Manufacturers Life Insurance) first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.9M in Q2 2024. 556 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 133,750 shares of BioMarin Pharmaceuticals worth $7.56M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,310 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $135K.
  • BioMarin Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #997 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s BioMarin Pharmaceuticals position peaked at $14.9M in Q2 2024.
  • 556 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.